{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:47:15Z","timestamp":1793468835220,"version":"4.5.0"},"reference-count":252,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Bruton\u2019s tyrosine kinase inhibitors (BTKis) have made substantial impacts on the treatment of B-cell malignancies like chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Therapeutic benefits aside, the clinical use of BTKis comes with several side effects, of which hypertension (HTN) is quite common and serious and of significant clinical concern. The present article will discuss the mechanisms by which the use of BTKis causes hypertension and outline strategies for managing the condition within the clinic. Studies indicate that using BTKis interferes with BTK\u2019s central role within the B-cell receptor (BCR) signaling cascade and impacts multiple downstream signaling pathways like PI3K\/Akt, MAPK, and NF-\u03baB. These changes contribute to endothelial dysfunction, increased oxidative stress, and vascular constriction, all of which are implicated in the development of hypertension. Of special concern is that oxidative stress (OS) is directly related to decreased endothelial nitric oxide (NO) production, a finding that becomes particularly relevant during the initiation of BTKi therapy. Also, BTKis affect vascular development and tone regulation by activating the Notch and RhoA\/ROCK pathways, leading to increased vasoconstriction and the advancement of hypertension. In light of the possibility that BTKi-induced hypertension might jeopardize treatment tolerability and patient outcomes, this review proposes a multimodal management of the condition, including careful monitoring of blood pressure, individualized antihypertensive treatment, and possible modifications of the dosing of BTKis. Future investigations should look into the specific molecular mechanisms underpinning the development of hypertension due to BTKis as well as the effects of various antihypertensive regimens on the improvement of the cardiovascular profile of affected individuals.<\/jats:p>","DOI":"10.3389\/fphar.2025.1585061","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T09:30:47Z","timestamp":1747301447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigation of the mechanism of hypertension caused by BTKi in the treatment of hematologic diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiayi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojian","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenJuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13045-022-01353-w","article-title":"BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies","volume":"15","author":"A Alu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ctrv.2016.12.002","article-title":"Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis","volume":"53","author":"Abdel-Qadir","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/VHRM.S170317","article-title":"Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents","volume":"14","author":"Aflyatumova","year":"2018","journal-title":"Vasc. Health Risk Manag."},{"key":"B4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s11886-023-01916-4","article-title":"Diagnosis and management of cardiovascular effects of Bruton's tyrosine kinase inhibitors","volume":"25","author":"Aghel","year":"2023","journal-title":"Curr. Cardiol. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"687458","DOI":"10.3389\/fimmu.2021.687458","article-title":"Targeting Bruton's tyrosine kinase in CLL","volume":"12","author":"Ahn","year":"2021","journal-title":"Front. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"642352","DOI":"10.3389\/fcell.2021.642352","article-title":"Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective","volume":"9","author":"Akil","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/antiox12020281","article-title":"Oxidative stress, antioxidants and hypertension","volume":"12","author":"Amponsah-Offeh","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11906-020-01064-y","article-title":"Endothelial dysfunction in patients with rheumatoid arthritis: the role of hypertension","volume":"22","author":"Anyfanti","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/14728222.2019.1641198","article-title":"The Notch pathway: a novel therapeutic target for cardiovascular diseases","volume":"23","author":"Aquila","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.120.15856","article-title":"Nitric oxide-cGMP signaling in hypertension: current and future options for pharmacotherapy","volume":"76","author":"Ataei Ataabadi","year":"2020","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1182\/bloodadvances.2022007938","article-title":"International consensus statement on the management of cardiovascular risk of Bruton's tyrosine kinase inhibitors in CLL","volume":"6","author":"Awan","year":"2022","journal-title":"Blood Adv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.ejca.2011.03.033","article-title":"The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer","volume":"47","author":"Bamias","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"B14","first-page":"358","article-title":"Oxidative stress and hypertension: possibility of hypertension therapy with antioxidants","volume":"19","author":"Baradaran","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3324\/haematol.2018.192328","article-title":"Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2","volume":"103","author":"Barr","year":"2018","journal-title":"Haematologica"},{"key":"B16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-023-01469-7","article-title":"Unresolved questions in selection of therapies for treatment-na\u00efve chronic lymphocytic leukemia","volume":"16","author":"Bennett","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"a006569","DOI":"10.1101\/cshperspect.a006569","article-title":"VEGF and Notch in tip and stalk cell selection","volume":"3","author":"Blanco","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nri3534","article-title":"Thymus involution and regeneration: two sides of the same coin","volume":"13","author":"Boehm","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cardiores.2007.06.004","article-title":"The importance of endothelin-1 for vascular dysfunction in cardiovascular disease","volume":"76","author":"B\u00f6hm","year":"2007","journal-title":"Cardiovasc Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-kappaB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.3324\/haematol.2014.119669","article-title":"Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages","volume":"100","author":"Borge","year":"2015","journal-title":"Haematologica"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1182\/bloodadvances.2019001204","article-title":"Is a BTKi or BCL2i preferable for first \u201cnovel\u201d therapy in CLL? The case for BTKis","volume":"6","author":"Brem","year":"2022","journal-title":"Blood Adv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1182\/blood.2024024667","article-title":"Sustained benefit of zanubrutinib vs ibrutinib in patients with R\/R CLL\/SLL: final comparative analysis of ALPINE","volume":"144","author":"Brown","year":"2024","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1078\/0171-2985-00192","article-title":"Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes","volume":"206","author":"Brunner","year":"2002","journal-title":"Immunobiology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/PPO.0000000000000412","article-title":"Bruton tyrosine kinase inhibitors: present and future","volume":"25","author":"Burger","year":"2019","journal-title":"CANCER J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","article-title":"B cell receptor signaling in chronic lymphocytic leukemia","volume":"34","author":"Burger","year":"2013","journal-title":"Trends Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/s0165-6147(02)02050-3","article-title":"EDHF: bringing the concepts together","volume":"23","author":"Busse","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"B29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/HYPERTENSIONAHA.122.17947","article-title":"Established and emerging cancer therapies and cardiovascular system: focus on hypertension-mechanisms and mitigation","volume":"80","author":"Butel-Simoes","year":"2023","journal-title":"Hypertension"},{"key":"B30","article-title":"ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of","volume-title":"Eur. Heart. J.","author":"B Williams","year":"2018"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-19-2856","article-title":"Ibrutinib treatment for first-line and relapsed\/refractory chronic lymphocytic leukemia: final analysis of the pivotal phase ib\/II PCYC-1102 study","volume":"26","author":"Byrd","year":"","journal-title":"Clin. Cancer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1200\/JCO.21.01210","article-title":"Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia: results of the first randomized phase III trial","volume":"39","author":"Byrd","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1182\/blood.2018884940","article-title":"Acalabrutinib monotherapy in patients with relapsed\/refractory chronic lymphocytic leukemia: updated phase 2 results","volume":"135","author":"Byrd","year":"","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/CMR.15.3.414-429.2002","article-title":"NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions","volume":"15","author":"Caama\u00f1o","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0211228","DOI":"10.1371\/journal.pone.0211228","article-title":"Ibrutinib increases the risk of hypertension and atrial fibrillation: systematic review and meta-analysis","volume":"14","author":"Caldeira","year":"2019","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/HJH.0b013e328010d4d2","article-title":"RhoA\/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans","volume":"25","author":"Cal\u00f2","year":"2007","journal-title":"J. Hypertens."},{"key":"B37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1242\/jcs.1994.supplement_18.18","article-title":"Specificity in recognition of phosphopeptides by src-homology 2 domains","volume":"18","author":"Cantley","year":"1994","journal-title":"J. Cell Sci. Suppl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/cvr\/cvp304","article-title":"Thyroid hormone stimulates NO production via activation of the PI3K\/Akt pathway in vascular myocytes","volume":"85","author":"Carrillo-Sep\u00falveda","year":"2010","journal-title":"Cardiovasc Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1080\/10428194.2017.1315115","article-title":"Practical recommendations for the choice of anticoagulants in the management of patients with atrial fibrillation on ibrutinib","volume":"58","author":"Chai","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"B40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-022-01302-7","article-title":"Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation","volume":"15","author":"Chen","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1200\/JCO.2013.52.6582","article-title":"Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation","volume":"32","author":"Chow","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"00296","DOI":"10.1016\/j.tem.2024.11.004","article-title":"Intracellular endothelial cell metabolism in vascular function and dysfunction","author":"Citrin","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11886-016-0780-3","article-title":"Integrating out-of-office blood pressure in the diagnosis and management of hypertension","volume":"18","author":"Cohen","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaccao.2019.11.009","article-title":"Hypertension in cancer patients and survivors: epidemiology, diagnosis, and management","volume":"1","author":"Cohen","year":"","journal-title":"JACC CardioOncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"853","DOI":"10.7326\/M19-0223","article-title":"Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis","volume":"170","author":"Cohen","year":"","journal-title":"Ann. Intern Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.rec.2021.05.002","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"74","author":"Collet","year":"2021","journal-title":"Rev. Esp. Cardiol. Engl. Ed."},{"key":"B47","first-page":"E10","article-title":"FDA grants accelerated approval for ibrutinib for CLL","volume":"20","author":"Dangi-Garimella","year":"2014","journal-title":"Am. J. Manag. Care"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1042\/CS103S001S","article-title":"Classification of endothelin receptors and antagonists in clinical development","volume":"103","author":"Davenport","year":"2002","journal-title":"Clin. Sci. (Lond)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"7540","DOI":"10.1158\/1078-0432.CCR-19-1009","article-title":"Decreased NOTCH1 activation correlates with response to ibrutinib in chronic lymphocytic leukemia","volume":"25","author":"Del Papa","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/v10080409","article-title":"Suppression of NF-\u03baB activity: a viral immune evasion mechanism","volume":"10","author":"Deng","year":"2018","journal-title":"Viruses"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e176142","DOI":"10.1172\/JCI176142","article-title":"BTK drives neutrophil activation for sterilizing antifungal immunity","volume":"134","author":"Desai","year":"2024","journal-title":"J. Clin. Invest"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01380","article-title":"Calcium in the pathophysiology of atrial fibrillation and heart failure","author":"Denham","year":"2018","journal-title":"Front. 9."},{"key":"B254","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1183\/13993003.00773-2015","article-title":"Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension","volume":"48","author":"Dabral","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.1073\/pnas.1602728113","article-title":"Transcription factors of the alternative NF-\u03baB pathway are required for germinal center B-cell development","volume":"113","author":"De Silva","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12291-015-0516-y","article-title":"Endothelial dysfunction in type 2 diabetes mellitus","volume":"31","author":"Dhananjayan","year":"2016","journal-title":"Indian J. Clin. Biochem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood.2019000840","article-title":"Hypertension and incident cardiovascular events following ibrutinib initiation","volume":"134","author":"Dickerson","year":"2019","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1200\/JCO.22.02830","article-title":"Zanubrutinib versus ibrutinib in symptomatic Waldenstr\u00f6m macroglobulinemia: final analysis from the randomized phase III ASPEN study","volume":"41","author":"Dimopoulos","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","author":"D Konukoglu","year":"2017","journal-title":"Hypertension"},{"key":"B58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2011.01.019","article-title":"Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress","volume":"216","author":"Doronzo","year":"2011","journal-title":"Atherosclerosis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018674","article-title":"Preclinical characterization of pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor. Blood","author":"Eb Gomez","year":"2023","journal-title":"J. Am. Soc. Hematol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/1521-4141(200107)31:7<2126::aid-immu2126>3.0.co;2-o","article-title":"Association of SLP-65\/BLNK with the B cell antigen receptor through a non-ITAM tyrosine of Ig-alpha","volume":"31","author":"Engels","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/antiox8100436","article-title":"Say NO to ROS: their roles in embryonic heart development and pathogenesis of congenital heart defects in maternal diabetes","volume":"8","author":"Engineer","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The MAPK signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","article-title":"Nitric oxide signalling in cardiovascular health and disease","volume":"15","author":"Farah","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1038\/ncomms7168","article-title":"Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor","volume":"6","author":"Freeman","year":"2015","journal-title":"Nat. Commun."},{"key":"B65","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1074-7613(00)00002-9","article-title":"Xid-like phenotypes: a B cell signalosome takes shape","volume":"13","author":"Fruman","year":"2000","journal-title":"Immunity"},{"key":"B67","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/21218","article-title":"Regulation of endothelium-derived nitric oxide production by the protein kinase Akt","volume":"399","author":"Fulton","year":"1999","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1021\/acs.jmedchem.0c00597","article-title":"A fast and clean BTK inhibitor","volume":"63","author":"Gabizon","year":"2020","journal-title":"J. Med. Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/ijms25052973","article-title":"New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications","volume":"25","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jacep.2018.06.004","article-title":"Ibrutinib-associated atrial fibrillation","volume":"4","author":"Ganatra","year":"2018","journal-title":"JACC Clin. Electrophysiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jaci.2010.09.007","article-title":"The germinal center reaction","volume":"126","author":"Gatto","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1158\/1055-9965.EPI-17-0510","article-title":"Blood pressure status in adult survivors of childhood cancer: a report from the st. Jude lifetime cohort study","volume":"26","author":"Gibson","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B255","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/cncr.34787","article-title":"Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: focus on hypertension and cardiovascular toxicity","volume":"129","author":"Gordon","year":"2023","journal-title":"Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2016.12.019","article-title":"Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis","volume":"109","author":"Godo","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/cancers8030036","article-title":"Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy","volume":"8","author":"Golubovskaya","year":"2016","journal-title":"Cancers (Basel)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/01.res.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm.2079","article-title":"The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure","volume":"16","author":"Guilluy","year":"2010","journal-title":"Nat. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00204-020-02689-3","article-title":"Antioxidants and antioxidant methods: an updated overview","volume":"94","author":"Gulcin","year":"2020","journal-title":"Arch. Toxicol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1258\/0007142991902295","article-title":"Redox imbalance in the critically ill","volume":"55","author":"Gutteridge","year":"1999","journal-title":"Br. Med. Bull."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s11606-020-05731-3","article-title":"Thiazide diuretic-induced change in fasting plasma glucose: a meta-analysis of randomized clinical trials","volume":"35","author":"Hall","year":"2020","journal-title":"J. Gen. Intern Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ajh.26859","article-title":"BTKi bonanza in CLL\/SLL: sorting out the differences","volume":"98","author":"Hampel","year":"2023","journal-title":"Am. J. Hematol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ncb3574","article-title":"Endothelial Notch signalling limits angiogenesis via control of artery formation","volume":"19","author":"Hasan","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1084\/jem.187.8.1235","article-title":"Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production","volume":"187","author":"Hata","year":"1998","journal-title":"J. Exp. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1253\/circj.cj-08-1102","article-title":"Endothelial function and oxidative stress in cardiovascular diseases","volume":"73","author":"Higashi","year":"2009","journal-title":"Circ. J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"H499","DOI":"10.1152\/ajpheart.00325.2011","article-title":"Endothelial dysfunction as a cellular mechanism for vascular failure","volume":"302","author":"Hirase","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/10623329809072198","article-title":"Thrombin stimulated reactive oxygen species production in cultured human endothelial cells","volume":"6","author":"Holland","year":"1998","journal-title":"Endothelium"},{"key":"B89","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni.2234","article-title":"The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils","volume":"13","author":"Honda","year":"2012","journal-title":"Nat. Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/01.cir.101.11.1234","article-title":"Vascular effects following homozygous disruption of p47(phox): an essential component of NADPH oxidase","volume":"101","author":"Hsich","year":"2000","journal-title":"Circulation"},{"key":"B92","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11912-018-0686-x","article-title":"Prevalence and risk of polypharmacy among elderly cancer patients receiving chemotherapy in ambulatory oncology setting","volume":"20","author":"I Goh","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00004872-200501000-00018","article-title":"Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress","volume":"23","author":"Imanishi","year":"2005","journal-title":"J. Hypertens."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrc.2017.121","article-title":"Targeting B cell receptor signalling in cancer: preclinical and clinical advances","volume":"18","author":"Ja Burger","year":"2018","journal-title":"Nat. Rev. CANCER"},{"key":"B96","doi-asserted-by":"publisher","first-page":"23420","DOI":"10.1074\/jbc.M202485200","article-title":"Convergence of signaling pathways on the activation of ERK in B cells","volume":"277","author":"Jacob","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B97","article-title":"Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation","volume-title":"Leukemia.","author":"Ja Gambril","year":"2024"},{"key":"B98","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S0140-6736(24)00595-6","article-title":"Chronic lymphocytic leukaemia","volume":"404","author":"Jain","year":"2024","journal-title":"Lancet."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1089\/ars.2009.2585","article-title":"Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets","volume":"11","author":"Jaquet","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.3390\/cancers16213574","article-title":"The immunomodulatory mechanisms of BTK inhibition in CLL and beyond","volume":"16","author":"Jiang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/383707a0","article-title":"Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia","volume":"383","author":"Joutel","year":"1996","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1128\/MCB.22.8.2524-2535.2002","article-title":"The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways","volume":"22","author":"Kabak","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.tvjl.2015.04.009","article-title":"The effects of surgery-induced immunosuppression and angiogenesis on tumour growth","volume":"205","author":"Kadosawa","year":"2015","journal-title":"Vet. J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/HJH.0000000000001197","article-title":"Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review","volume":"35","author":"Kallioinen","year":"2017","journal-title":"J. Hypertens."},{"key":"B106","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00006676-200204000-00007","article-title":"Expression of ROCK-1 in human pancreatic cancer: its down-regulation by morpholino oligo antisense can reduce the migration of pancreatic cancer cells in vitro","volume":"24","author":"Kaneko","year":"2002","journal-title":"Pancreas"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00277-017-2973-2","article-title":"Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib","volume":"96","author":"Kaur","year":"2017","journal-title":"Ann. Hematol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/cells10071681","article-title":"RhoA signaling in immune cell response and cardiac disease","volume":"10","author":"Kilian","year":"2021","journal-title":"Cells"},{"key":"B109","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/circresaha.121.318063","article-title":"Oxidative stress and hypertension","volume":"128","author":"Kk Griendling","year":"2021","journal-title":"Circulation"},{"key":"B110","doi-asserted-by":"publisher","first-page":"5393894","DOI":"10.1155\/2016\/5393894","article-title":"CD4(+) T cell fate in glomerulonephritis: a tale of Th1, Th17, and novel treg subtypes","volume":"2016","author":"Krebs","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2025.101268","article-title":"BTKi-induced cardiovascular toxicity in CLL: risk mitigation and management strategies","author":"K Sofija","year":"2025","journal-title":"Blood Rev."},{"key":"B112","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.atherosclerosis.2010.08.067","article-title":"PTEN overexpression attenuates angiogenic processes of endothelial cells by blockade of endothelin-1\/endothelin B receptor signaling","volume":"221","author":"Kuo","year":"2012","journal-title":"Atherosclerosis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244","article-title":"ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic","author":"L Ar Tlc","year":"2022","journal-title":"Eur. Heart J."},{"key":"B114","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/cvr\/cvs135","article-title":"The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles","volume":"95","author":"Lacolley","year":"2012","journal-title":"Cardiovasc Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/s0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/v10080409","article-title":"Suppression of NF-\u03baB activity: a viral immune evasion mechanism","volume":"10","author":"L Deng","year":"2018","journal-title":"Viruses-Basel"},{"key":"B117","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1161\/HYPERTENSIONAHA.122.17947","article-title":"Established and emerging cancer therapies and cardiovascular system: focus on hypertension\u2014mechanisms and mitigation","volume":"80","author":"LE Butel-Simoes","year":"2023","journal-title":"Hypertension"},{"key":"B118","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/HJH.0000000000003060","article-title":"Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension","volume":"40","author":"Li","year":"2022","journal-title":"J. Hypertens."},{"key":"B119","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/s0898-6568(00)00096-6","article-title":"Mechanical stress-initiated signal transductions in vascular smooth muscle cells","volume":"12","author":"Li","year":"2000","journal-title":"Cell Signal"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/ijms20092155","article-title":"Resveratrol and vascular function","volume":"20","author":"Li","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"","journal-title":"Science."},{"key":"B122","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/ng0797-243","article-title":"Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1","volume":"16","author":"Li","year":"","journal-title":"Nat. Genet."},{"key":"B123","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.lfs.2019.05.013","article-title":"Downregulation of endothelin A receptor (ETaR) ameliorates renal ischemia reperfusion injury by increasing nitric oxide production","volume":"228","author":"Li","year":"","journal-title":"Life Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/ars.2009.2854","article-title":"Age-related changes in redox signaling and VSMC function","volume":"12","author":"Li","year":"2010","journal-title":"Antioxid. Redox Signal"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/nm.2021","article-title":"Notch3 signaling promotes the development of pulmonary arterial hypertension","volume":"15","author":"Li","year":"2009","journal-title":"Nat. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/01.res.79.5.1007","article-title":"Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells, Role of Raf","volume":"79","author":"Liao","year":"1996","journal-title":"Circ. Res."},{"key":"B127","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ceb.2017.02.007","article-title":"PI3K signaling in cancer: beyond AKT","volume":"45","author":"Lien","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1182\/hematology.2020000118","article-title":"Managing toxicities of Bruton tyrosine kinase inhibitors","volume":"2020","author":"Lipsky","year":"2020","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e1251","DOI":"10.1038\/cddis.2014.229","article-title":"Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk\/MAP kinase pathway mediated by cAMP\/PKA signaling","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.21037\/atm-22-4314","article-title":"Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance","volume":"10","author":"Liu","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/HYPERTENSIONAHA.109.134353","article-title":"Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor","volume":"54","author":"L\u00f6hn","year":"2009","journal-title":"Hypertension"},{"key":"B132","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14715\/cmb\/2020.66.3.19","article-title":"Correlation of serum BNP and ET-1 levels with cardiac pump function and ventricular remodeling in patients with heart failure","volume":"66","author":"L Qin","year":"2020","journal-title":"Cell Mol. Biol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/01.res.66.4.1088","article-title":"Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins","volume":"66","author":"L\u00fcscher","year":"1990","journal-title":"Circ. Res."},{"key":"B134","article-title":"European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society IC","volume-title":"Eur. Heart. J.","author":"Lyon Tl","year":"2022"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0156-4","article-title":"CLOCK and BMAL1 stabilize and activate RHOA to promote F-actin formation in cancer cells","volume":"50","author":"Ma","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"10374","DOI":"10.3390\/ijms241210374","article-title":"Treatment refractoriness in chronic lymphocytic leukemia: old and new molecular biomarkers","volume":"24","author":"Maher","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"B138","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/MPH.0b013e3181ec0ede","article-title":"Immunosuppressant-induced endothelial damage and pulmonary arterial hypertension","volume":"33","author":"Mathew","year":"2011","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0140-6736(21)00224-5","article-title":"Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1\/2 study","volume":"397","author":"Mato","year":"2021","journal-title":"Lancet"},{"key":"B140","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/s0167-5699(97)01197-3","article-title":"Signal transduction through NF-kappa B","volume":"19","author":"May","year":"1998","journal-title":"Immunol. Today"},{"key":"B141","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bcp.2012.03.020","article-title":"Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease","volume":"84","author":"Mazzuca","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/jama.2014.10057","article-title":"Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial","volume":"312","author":"McManus","year":"2014","journal-title":"JAMA"},{"key":"B143","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/blood-2014-10-604272","article-title":"Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling","volume":"124","author":"McMullen","year":"2014","journal-title":"Blood"},{"key":"B144","first-page":"409","article-title":"Nitric oxide and NO-synthases in mammals in different functional states","volume":"65","author":"Menshikova","year":"2000","journal-title":"Biochem. (Mosc)."},{"key":"B145","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.3390\/ijms20153775","article-title":"Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS","volume":"20","author":"Meza","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.1128\/MCB.22.24.8467-8477.2002","article-title":"Rho GTPase\/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B\/Akt in human endothelial cells","volume":"22","author":"Ming","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"E58","DOI":"10.1161\/01.res.0000012569.55432.02","article-title":"Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide\/cGMP signaling","volume":"90","author":"Mollnau","year":"2002","journal-title":"Circ. Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/cvr\/cvn325","article-title":"Phosphoinositide 3-kinase signalling in the vascular system","volume":"82","author":"Morello","year":"2009","journal-title":"Cardiovasc Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"104408","DOI":"10.1016\/j.phrs.2019.104408","article-title":"Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses","volume":"148","author":"Morris","year":"","journal-title":"Pharmacol. Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1042\/CS20190835","article-title":"Notch3 signalling and vascular remodelling in pulmonary arterial hypertension","volume":"133","author":"Morris","year":"","journal-title":"Clin. Sci. (Lond)."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1182\/bloodadvances.2023011641","article-title":"Cardiovascular events reported in patients with B-cell malignancies treated with zanubrutinib","volume":"8","author":"Moslehi","year":"2024","journal-title":"Blood Adv."},{"key":"B153","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3390\/ijms25063234","article-title":"Targeting BTK in B cell malignancies: from mode of action to resistance mechanisms","volume":"25","author":"Mouhssine","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B154","doi-asserted-by":"crossref","DOI":"10.1097\/01.HS9.0000845584.91358.28","article-title":"P675: treatment of hypertension in patients receiving BTK inhibitors: a multicenter retrospective study","volume-title":"HemaSphere","author":"M Shadman","year":"2022"},{"key":"B155","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-981-13-9367-9_10","article-title":"NF-\u03baB, I\u03baB, and IKK: integral components of immune system signaling","volume":"1172","author":"Mulero","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/ajh.25638","article-title":"Final analysis from RESONATE: up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma","volume":"94","author":"Munir","year":"2019","journal-title":"Am. J. Hematol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacc.2018.10.069","article-title":"Blood pressure assessment in adults in clinical practice and clinic-based research: JACC scientific expert panel","volume":"73","author":"Muntner","year":"","journal-title":"J. Am. Coll. Cardiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of blood pressure in humans: a scientific statement from the American heart association","volume":"73","author":"Muntner","year":"","journal-title":"Hypertension"},{"key":"B159","doi-asserted-by":"publisher","first-page":"107123","DOI":"10.1016\/j.intimp.2020.107123","article-title":"Bruton's tyrosine kinase inhibition attenuates oxidative stress in systemic immune cells and renal compartment during sepsis-induced acute kidney injury in mice","volume":"90","author":"Nadeem","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bjh.18418","article-title":"Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma","volume":"200","author":"Nakhoda","year":"2023","journal-title":"Br. J. Haematol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"668131","DOI":"10.3389\/fcell.2021.668131","article-title":"Targeting Bruton's tyrosine kinase in inflammatory and autoimmune pathologies","volume":"9","author":"Neys","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B163","doi-asserted-by":"crossref","DOI":"10.1201\/9780429281082-2","article-title":"The development of beta receptor agonist drugs","volume-title":"The role of beta receptor agonist therapy in","author":"O'Donnell","year":"2020"},{"key":"B164","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/s1074-7613(00)00079-0","article-title":"BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation","volume":"13","author":"Okada","year":"2000","journal-title":"Immunity"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"key":"B166","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1021\/acs.jmedchem.1c01170","article-title":"Discovery of reversible covalent Bruton's tyrosine kinase inhibitors PRN473 and PRN1008 (rilzabrutinib)","volume":"65","author":"Owens","year":"2022","journal-title":"J. Med. Chem."},{"key":"B167","doi-asserted-by":"publisher","first-page":"14483","DOI":"10.1073\/pnas.94.26.14483","article-title":"Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II","volume":"94","author":"Pagano","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B168","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton's tyrosine kinase in B cells and malignancies","volume":"17","author":"Pal","year":"2018","journal-title":"Mol. Cancer"},{"key":"B169","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.seminhematol.2024.04.002","article-title":"Targeting the B cell receptor signaling pathway in chronic lymphocytic leukemia","volume":"61","author":"Patton","year":"2024","journal-title":"Semin. Hematol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.niox.2010.04.007","article-title":"Regulation of the expression of inducible nitric oxide synthase","volume":"23","author":"Pautz","year":"2010","journal-title":"Nitric Oxide"},{"key":"B171","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume-title":"N Engl J Med.","author":"P Kirchhof","year":"2020"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jacc.2005.10.073","article-title":"Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression","volume":"47","author":"Petrakopoulou","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/cancers14040860","article-title":"Regulation of B-cell receptor signaling and its therapeutic relevance in aggressive B-cell lymphomas","volume":"14","author":"Profit\u00f3s-Pelej\u00e0","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B174","doi-asserted-by":"publisher","first-page":"e51514","DOI":"10.1371\/journal.pone.0051514","article-title":"Notch signaling change in pulmonary vascular remodeling in rats with pulmonary hypertension and its implication for therapeutic intervention","volume":"7","author":"Qiao","year":"2012","journal-title":"PLoS One"},{"key":"B175","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","article-title":"Role of PI3K\/Akt signaling pathway in cardiac fibrosis","volume":"476","author":"Qin","year":"2021","journal-title":"Mol. Cell Biochem."},{"key":"B176","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jaccao.2023.09.002","article-title":"Cardiovascular toxicities of BTK inhibitors in chronic lymphocytic leukemia: JACC: CardioOncology state-of-the-art review","volume":"5","author":"Quartermaine","year":"2023","journal-title":"JACC CardioOncol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","article-title":"Transcription factors of the NFAT family: regulation and function","volume":"15","author":"Rao","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fphar.2014.00057","article-title":"Acute nitric oxide synthase inhibition and endothelin-1-dependent arterial pressure elevation","volume":"5","author":"Rapoport","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrc3546","article-title":"Endothelin 1 in cancer: biological implications and therapeutic opportunities","volume":"13","author":"Rosan\u00f2","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B180","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.4049\/jimmunol.1301328","article-title":"A cell-intrinsic requirement for NF-\u03baB-inducing kinase in CD4 and CD8 T cell memory","volume":"191","author":"Rowe","year":"2013","journal-title":"J. Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41375-023-01830-2","article-title":"A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia","volume":"37","author":"Ryan","year":"2023","journal-title":"Leukemia"},{"key":"B182","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.molcel.2004.12.012","article-title":"RhoA GTPase regulates B cell receptor signaling","volume":"17","author":"Saci","year":"2005","journal-title":"Mol. Cell"},{"key":"B183","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1038\/s41598-022-09757-x","article-title":"p38 MAPK priming boosts VSMC proliferation and arteriogenesis by promoting PGC1\u03b1-dependent mitochondrial dynamics","volume":"12","author":"Sah\u00fan-Espa\u00f1ol","year":"2022","journal-title":"Sci. Rep."},{"key":"B184","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/s1074-7613(03)00297-8","article-title":"BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity","volume":"19","author":"Saito","year":"2003","journal-title":"Immunity"},{"key":"B185","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1182\/bloodadvances.2023011569","article-title":"Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study","volume":"8","author":"Samples","year":"2024","journal-title":"Blood Adv."},{"key":"B186","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaccao.2021.01.007","article-title":"Contribution of polygenic risk to hypertension among long-term survivors of childhood cancer","volume":"3","author":"Sapkota","year":"2021","journal-title":"Cardio Oncol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.ajkd.2006.10.014","article-title":"Antihypertensive therapy in the presence of proteinuria","volume":"49","author":"Sarafidis","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"B188","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.4049\/jimmunol.1400798","article-title":"CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells","volume":"193","author":"Schwartz","year":"2014","journal-title":"J. Immunol."},{"key":"B190","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/jcm9051328","article-title":"ROCK (RhoA\/Rho kinase) in cardiovascular-renal pathophysiology: a review of new advancements","volume":"9","author":"Seccia","year":"2020","journal-title":"J. Clin. Med."},{"key":"B191","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11912-021-01102-1","article-title":"Bruton's tyrosine kinase inhibitors and cardiotoxicity: more than just atrial fibrillation","volume":"23","author":"Sestier","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"B192","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3324\/haematol.2024.285754","article-title":"Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I\/II BRUIN trial","volume":"110","author":"Shah","year":"2025","journal-title":"Haematologica"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/01.RES.0000165483.34603.91","article-title":"Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery","volume":"96","author":"Shiga","year":"2005","journal-title":"Circ. Res."},{"key":"B194","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.4049\/jimmunol.179.6.3872","article-title":"Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family","volume":"179","author":"Shinners","year":"2007","journal-title":"J. Immunol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1152\/physrev.00005.2017","article-title":"Notch signaling in development, tissue homeostasis, and disease","volume":"97","author":"Siebel","year":"2017","journal-title":"Physiol. Rev."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1113\/jphysiol.2007.131201","article-title":"Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice","volume":"581","author":"Slowinski","year":"2007","journal-title":"J. Physiol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"689472","DOI":"10.3389\/fimmu.2021.689472","article-title":"Resistance mutations to BTK inhibitors originate from the NF-\u03baB but not from the PI3K-RAS-MAPK arm of the B cell receptor signaling pathway","volume":"12","author":"Smith","year":"2021","journal-title":"Front. Immunol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1165\/rcmb.2014-0235OC","article-title":"Notch activation of Ca(2+) signaling in the development of hypoxic pulmonary vasoconstriction and pulmonary hypertension","volume":"53","author":"Smith","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1006\/bbrc.2000.2343","article-title":"Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells","volume":"269","author":"Somlyo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B200","doi-asserted-by":"publisher","first-page":"240","DOI":"10.21147\/j.issn.1000-9604.2024.03.02","article-title":"Evidence-based expert consensus on clinical management of safety of Bruton's tyrosine kinase inhibitors (2024)","volume":"36","author":"Song","year":"2024","journal-title":"Chin. J. Cancer Res."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/ni.1666","article-title":"Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling","volume":"9","author":"Stadanlick","year":"2008","journal-title":"Nat. Immunol."},{"key":"B202","first-page":"3645","article-title":"Rho kinase proteins-pleiotropic modulators of cell survival and apoptosis","volume":"31","author":"Street","year":"2011","journal-title":"Anticancer Res."},{"key":"B203","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur. Heart J."},{"key":"B204","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1111\/j.1742-4658.2008.06488.x","article-title":"Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species","volume":"275","author":"Sumimoto","year":"2008","journal-title":"FEBS J."},{"key":"B205","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1182\/bloodadvances.2023012221","article-title":"BTK inhibitors in CLL: second-generation drugs and beyond","volume":"8","author":"Tam","year":"2024","journal-title":"Blood Adv."},{"key":"B207","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.3390\/molecules26237411","article-title":"The development of BTK inhibitors: a five-year update","volume":"26","author":"Tasso","year":"2021","journal-title":"Molecules"},{"key":"B209","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.thorsurg.2018.12.001","article-title":"The role of the thymus in the immune response","volume":"29","author":"Thapa","year":"2019","journal-title":"Thorac. Surg. Clin."},{"key":"B210","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-1-60761-500-2_18","article-title":"Notch signaling in pulmonary hypertension","volume":"661","author":"Thistlethwaite","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/acschembio.8b01094","article-title":"PROTAC-mediated degradation of Bruton's tyrosine kinase is inhibited by covalent binding","volume":"14","author":"Tinworth","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms25010010","article-title":"B-cell receptor signaling and beyond: the role of Ig\u03b1 (CD79a)\/Ig\u03b2 (CD79b) in normal and malignant B cells","volume":"25","author":"Tkachenko","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/jcm9051328","article-title":"ROCK (RhoA\/Rho kinase) in cardiovascular\u2013renal pathophysiology: a review of new advancements","volume":"9","author":"Tm Seccia","year":"2020","journal-title":"J. Clin. Med."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1182\/blood.2022017235","article-title":"How I use genomics and BTK inhibitors in the treatment of Waldenstr\u00f6m macroglobulinemia","volume":"143","author":"Treon","year":"2024","journal-title":"Blood"},{"key":"B215","article-title":"International Society of Hypertension global hypertension practice guidelines","author":"T Unger","year":"2020"},{"key":"B216","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/abbs\/gmq102","article-title":"Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox","volume":"42","author":"T Zou","year":"2010","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B217","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41569-020-00437-9","article-title":"Lifestyle interventions for the prevention and treatment of hypertension","volume":"18","author":"Valenzuela","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40959-024-00237-x","article-title":"Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)-an analysis of an administrative health claims database","volume":"10","author":"Vallabhaneni","year":"2024","journal-title":"Cardiooncology"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/ni.1678","article-title":"Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling","volume":"9","author":"Vallabhapurapu","year":"2008","journal-title":"Nat. Immunol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm3290","article-title":"PI3K signalling: the path to discovery and understanding","volume":"13","author":"Vanhaesebroeck","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease - a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol. (Oxf)"},{"key":"B223","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/hc0502.104540","article-title":"Fundamentals of endothelial function for the clinical cardiologist","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"B224","doi-asserted-by":"publisher","first-page":"101655","DOI":"10.1016\/j.redox.2020.101655","article-title":"Nox2 activation in covid-19","volume":"36","author":"Violi","year":"2020","journal-title":"Redox Biol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40164-022-00315-9","article-title":"Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect","volume":"11","author":"Wang","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/hon.2933","article-title":"The resistance mechanisms and treatment strategies of BTK inhibitors in B-cell lymphoma","volume":"39","author":"Wang","year":"2021","journal-title":"Hematol. Oncol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1200\/JCO.23.00562","article-title":"Pirtobrutinib in covalent bruton tyrosine kinase inhibitor pretreated mantle-cell lymphoma","volume":"41","author":"Wang","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1346905","DOI":"10.3389\/fphar.2024.1346905","article-title":"Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cpt.85","article-title":"Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies","volume":"97","author":"Wang","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1089\/ars.2007.1998","article-title":"Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension","volume":"10","author":"Watson","year":"2008","journal-title":"Antioxid. Redox Signal"},{"key":"B231","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1021\/acs.jmedchem.9b00167","article-title":"Discovery of branebrutinib (BMS-986195): a strategy for identifying a highly potent and selective covalent inhibitor providing rapid in vivo inactivation of Bruton's tyrosine kinase (BTK)","volume":"62","author":"Watterson","year":"2019","journal-title":"J. Med. Chem."},{"key":"B232","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-065X.2010.00934.x","article-title":"Role of PI3K in the generation and survival of B cells","volume":"237","author":"Werner","year":"2010","journal-title":"Immunol. Rev."},{"key":"B233","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"key":"B234","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton Rmc","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/bloodadvances.2017009720","article-title":"Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib","volume":"1","author":"Wiczer","year":"2017","journal-title":"Blood Adv."},{"key":"B236","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1034\/j.1399-0012.17.s9.1.x","article-title":"Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction","volume":"17","author":"Wilasrusmee","year":"2003","journal-title":"Clin. Transpl."},{"key":"B237","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib","volume":"370","author":"Woyach","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B238","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1182\/blood-2012-02-362624","article-title":"The B-cell receptor signaling pathway as a therapeutic target in CLL","volume":"120","author":"Woyach","year":"2012","journal-title":"Blood"},{"key":"B239","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1089\/ars.2020.8112","article-title":"Oxidative stress, GTPCH1, and endothelial nitric oxide synthase uncoupling in hypertension","volume":"34","author":"Wu","year":"2021","journal-title":"Antioxid. Redox Signal"},{"key":"B240","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/01.atv.19.1.73","article-title":"Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells","volume":"19","author":"Xi","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mce.2013.01.007","article-title":"Activation of RhoA\/ROCK regulates NF-\u03baB signaling pathway in experimental diabetic nephropathy","volume":"369","author":"Xie","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1172\/JCI76881","article-title":"Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation","volume":"125","author":"Xie","year":"2015","journal-title":"J. Clin. Invest"},{"key":"B243","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.arr.2017.11.002","article-title":"FOXO1\/3: potential suppressors of fibrosis","volume":"41","author":"Xin","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"B244","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1073\/pnas.96.2.657","article-title":"Nitric oxide synthase in cardiac sarcoplasmic reticulum","volume":"96","author":"Xu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B245","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/01.hyp.30.1.106","article-title":"Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension","volume":"30","author":"Xu","year":"1997","journal-title":"Hypertension"},{"key":"B246","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"B247","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00277-023-05486-x","article-title":"Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia\/small lymphocytic lymphoma: a systematic review and meta-analysis","volume":"103","author":"Yin","year":"2024","journal-title":"Ann. Hematol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1182\/blood-2024-201309","article-title":"CD93+ myeloid cells suppress T-cell-mediated anti-tumor immunity","volume":"144","author":"Yu Yq","year":"2024","journal-title":"Blood"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/ijms20081820","article-title":"BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine","volume":"20","author":"Z Cao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd003654.pub5","article-title":"Calcium channel blockers versus other classes of drugs for hypertension. Cochrane database 2021","author":"Zhu","year":"2021"},{"key":"B250","doi-asserted-by":"publisher","first-page":"115475","DOI":"10.1016\/j.biopha.2023.115475","article-title":"Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: emphasis on oxidative stress","volume":"167","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B251","doi-asserted-by":"publisher","first-page":"113820","DOI":"10.1016\/j.ejmech.2021.113820","article-title":"Discovery of novel BTK PROTACs for B-Cell lymphomas","volume":"225","author":"Zhao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B252","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1585061\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T08:52:25Z","timestamp":1747385545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1585061\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":252,"alternative-id":["10.3389\/fphar.2025.1585061"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1585061","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"1585061"}}